Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Trifluoperazine adverse reaction |
Causative agent (attribute) |
False |
Trifluoperazine hydrochloride |
Inferred relationship |
Some |
|
Trifluoperazine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Trifluoperazine hydrochloride |
Inferred relationship |
Some |
|
Trifluoperazine hydrochloride 2 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Trifluoperazine hydrochloride |
Inferred relationship |
Some |
|
Trifluoperazine hydrochloride 10 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Trifluoperazine hydrochloride |
Inferred relationship |
Some |
|
Trifluoperazine hydrochloride 10mg/mL solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Trifluoperazine hydrochloride |
Inferred relationship |
Some |
|
Trifluoperazine hydrochloride 2mg/mL injection solution 10mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Trifluoperazine hydrochloride |
Inferred relationship |
Some |
|
Trifluoperazine hydrochloride 2 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Trifluoperazine hydrochloride |
Inferred relationship |
Some |
1 |
Trifluoperazine hydrochloride 2 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Trifluoperazine hydrochloride |
Inferred relationship |
Some |
1 |
Trifluoperazine hydrochloride 10 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Trifluoperazine hydrochloride |
Inferred relationship |
Some |
1 |
Trifluoperazine hydrochloride 10 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Trifluoperazine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely trifluoperazine (as trifluoperazine hydrochloride) 2 milligram/1 each prolonged-release oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Trifluoperazine hydrochloride |
Inferred relationship |
Some |
1 |
Trifluoperazine (as trifluoperazine hydrochloride) 10 mg prolonged-release oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Trifluoperazine hydrochloride |
Inferred relationship |
Some |
1 |
Trifluoperazine (as trifluoperazine hydrochloride) 15 mg prolonged-release oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Trifluoperazine hydrochloride |
Inferred relationship |
Some |
1 |
Trifluoperazine hydrochloride 2 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Trifluoperazine hydrochloride |
Inferred relationship |
Some |
1 |
Trifluoperazine hydrochloride 10 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Trifluoperazine hydrochloride |
Inferred relationship |
Some |
1 |
Trifluoperazine (as trifluoperazine hydrochloride) 1 mg/mL oral solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Trifluoperazine hydrochloride |
Inferred relationship |
Some |
1 |
Trifluoperazine (as trifluoperazine hydrochloride) 200 microgram/mL oral solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Trifluoperazine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely trifluoperazine (as trifluoperazine hydrochloride) 1 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Trifluoperazine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely trifluoperazine (as trifluoperazine hydrochloride) 5 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Trifluoperazine hydrochloride |
Inferred relationship |
Some |
1 |